Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,482	1,323	537	1,632	867	192
Market Cap Growth	176.23%	146.40%	-67.12%	88.21%	352.15%	17.84%
Enterprise Value	1,850	1,002	274	1,286	674	62
Last Close Price	40.65	22.93	10.91	34.20	20.16	7.05
PS Ratio	7.67	22.04	20.19	59.67	30.29	830.33
PB Ratio	4.55	3.93	2.49	5.44	3.10	2.40
P/TBV Ratio	4.98	3.93	2.49	5.44	3.10	2.40
P/FCF Ratio	10.98	-	-	-	-	-
P/OCF Ratio	10.93	-	-	-	-	-
EV/Sales Ratio	5.71	16.69	10.29	47.01	23.53	266.73
EV/FCF Ratio	8.07	-	-	-	-	-
Debt / Equity Ratio	0.02	0.00	0.02	0.02	0.02	0.21
Asset Turnover	0.69	0.20	0.09	0.08	0.12	0.00
Quick Ratio	10.57	16.54	7.61	7.55	7.69	3.97
Current Ratio	10.70	16.71	7.80	7.74	7.84	4.10
Return on Equity (ROE)	40.97%	-28.59%	-49.41%	-43.32%	-36.79%	-80.20%
Return on Assets (ROA)	19.96%	-19.32%	-27.57%	-23.40%	-16.82%	-34.19%
Return on Capital (ROIC)	22.01%	-21.01%	-31.27%	-26.60%	-21.08%	-48.05%
Earnings Yield	6.79%	-5.97%	-23.73%	-7.69%	-7.63%	-40.24%
FCF Yield	9.11%	-5.36%	-20.29%	-6.68%	-8.41%	-22.15%
Buyback Yield / Dilution	-17.78%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%
Total Shareholder Return	-17.78%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%

Source: S&P Capital IQ. Standard template. Financial Sources.